Bernice Ting is an experienced Global Analyst with a background in Health Economic outcome research, market access, and pricing analysis. She has worked in both the UK and Asian markets, with a particular focus on assisting in regulatory and HTA submissions. Ting has an MSc in Economic Evaluation in Healthcare, Pharmacoeconomics/Pharmaceutical Economics from City, University of London.

Ting's expertise lies in Global HEOR & MA, Patient Outcomes and Real World Evidence, procurement, policy analysis, and pharmacy. She has worked at PRIORITIS Market Access as a Senior Analyst, and has previously held roles at Eli Lilly and Company, The Ministry of Health Malaysia, Kuala Lumpur General Hospital, and Children's Cancer Hospital - Egypt 57357.